Innovative Technology Correlia Biosystems offers a proprietary PIXI platform that enables rapid, low-volume biomolecular analysis, providing unique opportunities to target research facilities seeking cutting-edge tools for quick biological insights.
Recent Product Launch The recent launch of their ELISA platform tailored for small sample sizes positions the company to attract customers interested in sensitive and efficient assays, especially in biotech and clinical research markets.
Funding Advantage With over 9.6 million in funding and a current revenue estimate of up to 10 million, Correlia Biosystems is positioned for growth, making them an attractive partner for investors and collaborative research projects.
Market Positioning Operating in a competitive landscape with major players like QIAGEN and Bio-Rad, Correlia’s innovative microscale tools can appeal to labs seeking more efficient, cost-effective solutions for biomolecular interaction analysis.
Potential Customer Base Targeting small to mid-sized biotech and research organizations that require high-throughput, rapid results with minimal sample consumption presents a strong sales opportunity for their advanced platform solutions.
$1B$10B
$1B$10B
$10B
$500M$1B
$1B$10B
$1B$10B
$10B
$10B
$1B$10B
$1B$10BCorrelia Biosystems uses 8 technology products and services including oEmbed, Shopify, Font Awesome, and more. Explore Correlia Biosystems's tech stack below.
| Correlia Biosystems Email Formats | Percentage |
| FLast@correliabio.com | 33% |
| First.Last@correliabio.com | 19% |
| First@correliabio.com | 15% |
| FLast@correliabio.com | 33% |
Biotechnology ResearchCalifornia, United States2-10 Employees
Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules. The customizable PIXI platform opens up new biological questions for interrogation from less than two microliters of sample, with rapid results that allow for dynamic monitoring of protein expression profiles.
Company Overview
Funding & FinancialsCorrelia Biosystems has raised a total of $9.6M of funding over 10 rounds. Their latest funding round was raised on Oct 16, 2020 in the amount of $9.6M.
Correlia Biosystems's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsCorrelia Biosystems has raised a total of $9.6M of funding over 10 rounds. Their latest funding round was raised on Oct 16, 2020 in the amount of $9.6M.
Correlia Biosystems's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com